BioMarin Pharmaceutical
BioMarin Pharmaceutical
biomarin.com

Locations

United States · North America · San Rafael, CA, USA

industry

Biotechnology · DeepTech · Software

Size

1001-5000 employees

Stage

Other

founded in

1997

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.

Something looks off?
Open jobs at BioMarin Pharmaceutical
Powered by Getro